Cas no 20098-19-5 (4-aminoadamantan-1-ol hydrochloride, Mixture of isomers)
4-aminoadamantan-1-ol hydrochloride, Mixture of isomers Chemical and Physical Properties
Names and Identifiers
-
- 4-Aminoadamantan-1-ol hydrochloride
- (E)-4-aminoadamantan-1-ol hydrochloride
- (E)-4-amino-adamantan-1-ol hydrochloride
- (E)-5-hydroxy-2-aminoadamantane
- 1-hydroxy-4-aminoadamantane hydrochloride
- 4-aminoadamantan-1-ol
- 4-amino-adamantan-1-ol hydrochloride
- 5-hydroxy-2-adamantylamine
- AK-94773
- E-4-aminoadamantan-1-ol hydrochloride
- syn-4-aminoadamantan-1-ol
- trans-4-aminoadamantan-1-ol
- trans-4-amino-adamantan-1-ol hydrochloride salt
- 4-Amino-tricyclo[3.3.1.1(3,7)]decan-1-ol hydrochloride
- 4-aminoadamantan-1-ol hydrochloride, Mixture of isomers
- KWEPNQFVPHYHHO-UHFFFAOYSA-N
- SY047090
- Cis-4-aminoadamantan-1-ol hydrochloride
- 4-Aminoadamantan-1-olhydrochloride
- 4-amino-1-adamantanol hydrochloride
- SCHEMBL525719
- 4-aminoadamantan-1-ol;hydrochloride
- 20098-19-5
- EN300-88448
- A833566
- cis-4-Aminoadamantan-1-ol HCl
- AKOS025401674
- CS-0131218
- 62075-23-4
- Z2736917439
- trans-1-Amino-4-hydroxyadamantane Hydrochloride
- (1s,4r)-4-aminoadamantan-1-ol hydrochloride
- EN300-6490144
- (1r,4s)-4-aminoadamantan-1-ol hydrochloride
- AKOS026743345
- trans-4-Amino-1-adamantanol Hydrochloride
- MFCD22194311
- EN300-1695479
- BS-35826
- MFCD01825646
- 62075-26-7
- 4-aminoadamantan-1-ol hydrochloride;trans-4-Aminoadamantan-1-ol hydrochloride
- AKOS000425261
- AC-24312
- AM20070537
- Tricyclo[3.3.1.13,7]decan-1-ol, 4-amino-, hydrochloride (1:1)
- FT-0650106
- SCHEMBL1587290
- Z3220041497
- (1S,3S)-4-Amino-1-adamantanol hydrochloride (1:1)
- A2594
- trans-4-Aminoadamantan-1-ol Hydrochloride
- DB-073048
-
- MDL: MFCD01838554
- Inchi: 1S/C10H17NO.ClH/c11-9-7-1-6-2-8(9)5-10(12,3-6)4-7;/h6-9,12H,1-5,11H2;1H
- InChI Key: KWEPNQFVPHYHHO-UHFFFAOYSA-N
- SMILES: Cl.OC12CC3CC(C1)C(C(C3)C2)N
Computed Properties
- Exact Mass: 203.1076919g/mol
- Monoisotopic Mass: 203.1076919g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 0
- Complexity: 200
- Covalently-Bonded Unit Count: 2
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 2
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 46.2?2
Experimental Properties
- PSA: 46.25000
- LogP: 2.38700
4-aminoadamantan-1-ol hydrochloride, Mixture of isomers Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 038591-1g |
4-Aminoadamantan-1-ol hydrochloride |
20098-19-5 | 1g |
1461CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 038591-5g |
4-Aminoadamantan-1-ol hydrochloride |
20098-19-5 | 5g |
5136CNY | 2021-05-07 | ||
| eNovation Chemicals LLC | D783033-5g |
4-amino-1-adamantanol |
20098-19-5 | 97% | 5g |
$300 | 2024-06-05 | |
| eNovation Chemicals LLC | D783033-25g |
4-amino-1-adamantanol |
20098-19-5 | 97% | 25g |
$850 | 2024-06-05 | |
| abcr | AB214294-250 mg |
4-Amino-1-adamantanol hydrochloride; 95% |
20098-19-5 | 250 mg |
€231.70 | 2023-07-20 | ||
| abcr | AB214294-1 g |
4-Amino-1-adamantanol hydrochloride; 95% |
20098-19-5 | 1 g |
€385.20 | 2023-07-20 | ||
| Chemenu | CM538506-5g |
4-Aminoadamantan-1-ol hydrochloride |
20098-19-5 | 95%+ | 5g |
$*** | 2023-03-29 | |
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 038591-1g |
4-Aminoadamantan-1-ol hydrochloride |
20098-19-5 | 1g |
1461.0CNY | 2021-07-13 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 038591-5g |
4-Aminoadamantan-1-ol hydrochloride |
20098-19-5 | 5g |
5136.0CNY | 2021-07-13 | ||
| Enamine | EN300-1695479-0.05g |
4-aminoadamantan-1-ol hydrochloride |
20098-19-5 | 95.0% | 0.05g |
$19.0 | 2025-02-20 |
4-aminoadamantan-1-ol hydrochloride, Mixture of isomers Related Literature
-
Philipp Traber,Stephan Kupfer,Stefanie Gr?fe,Isabelle Baussanne,Martine Demeunynck,Jean-Marie Mouesca,Serge Gambarelli,Vincent Artero,Murielle Chavarot-Kerlidou Chem. Sci., 2018,9, 4152-4159
-
Yaqing Liu,Jiangtao Ren,Jing Li,Jiyang Liu,Erkang Wang Chem. Commun., 2012,48, 802-804
-
Mengke Li,Xinyi Cai,Zhenyang Qiao,Wentao Xie,Liangying Wang,Nan Zheng,Shi-Jian Su Chem. Commun., 2019,55, 7215-7218
-
Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
-
L. Di Michele,D. Fiocco,F. Varrato,E. Eiser,G. Foffi Soft Matter, 2014,10, 3633-3648
Additional information on 4-aminoadamantan-1-ol hydrochloride, Mixture of isomers
4-Aminoadamantan-1-ol Hydrochloride, Mixture of Isomers (CAS No. 20098-19-5): A Comprehensive Overview
4-Aminoadamantan-1-ol hydrochloride, mixture of isomers (CAS No. 20098-19-5) is a unique chemical compound that has garnered significant attention in pharmaceutical and materials science research. This adamantane derivative, characterized by its rigid cage-like structure, offers intriguing properties that make it valuable for various applications. The mixture of isomers aspect adds another layer of complexity and utility to this compound, as different isomers can exhibit distinct biological activities and physicochemical properties.
The adamantane core structure, which forms the backbone of 4-aminoadamantan-1-ol hydrochloride, is known for its exceptional stability and three-dimensional symmetry. This structural feature contributes to the compound's ability to interact with biological targets in specific ways, making it particularly interesting for drug discovery efforts. Researchers have explored its potential in addressing current healthcare challenges, including the development of novel therapeutic agents for neurological conditions.
From a chemical perspective, 4-aminoadamantan-1-ol hydrochloride presents several noteworthy characteristics. The hydrochloride salt form enhances the compound's solubility in aqueous media, which is crucial for biological applications. The presence of both amino and hydroxyl functional groups on the adamantane framework allows for diverse chemical modifications, enabling researchers to create derivatives with tailored properties. These structural features have made this compound a valuable building block in medicinal chemistry.
The pharmaceutical industry has shown growing interest in adamantane derivatives like 4-aminoadamantan-1-ol hydrochloride due to their potential therapeutic benefits. Current research trends focus on exploring these compounds for their possible neuroprotective effects and their ability to modulate various biological pathways. The mixture of isomers presents an opportunity to study structure-activity relationships, which is particularly relevant in the context of personalized medicine approaches.
In material science applications, 4-aminoadamantan-1-ol hydrochloride has demonstrated utility as a precursor for advanced materials. Its rigid structure can impart desirable mechanical properties to polymers, and its functional groups allow for incorporation into various polymeric matrices. Researchers are investigating its potential in creating materials with enhanced thermal stability and unique optical properties, addressing current demands in high-performance materials development.
The synthesis and characterization of 4-aminoadamantan-1-ol hydrochloride, mixture of isomers require specialized expertise in organic chemistry. Modern analytical techniques such as NMR spectroscopy, mass spectrometry, and X-ray crystallography are typically employed to confirm the structure and purity of this compound. These characterization methods are particularly important when working with isomeric mixtures, as they help identify and quantify the individual components.
Quality control considerations for 4-aminoadamantan-1-ol hydrochloride are paramount, especially for pharmaceutical applications. Current Good Manufacturing Practice (cGMP) standards dictate rigorous testing protocols to ensure batch-to-batch consistency. The presence of isomers adds complexity to these quality assessments, requiring sophisticated chromatographic methods for proper analysis and standardization.
From a regulatory standpoint, 4-aminoadamantan-1-ol hydrochloride falls under general chemical regulations rather than specialized controlled substance categories. However, researchers and manufacturers must stay informed about evolving chemical regulations, particularly concerning adamantane derivatives and their potential applications. Proper handling procedures should always be followed, with appropriate safety measures in place for laboratory work involving this compound.
The commercial availability of 4-aminoadamantan-1-ol hydrochloride, mixture of isomers has increased in recent years, reflecting growing research interest. Several specialty chemical suppliers now offer this compound in various quantities and purity grades. Pricing typically reflects the complexity of synthesis and purification, especially considering the isomeric mixture aspect. Researchers should carefully evaluate supplier credentials and analytical data when sourcing this material.
Future research directions for 4-aminoadamantan-1-ol hydrochloride appear promising. The compound's unique structural features continue to inspire investigations across multiple disciplines. Current trends suggest particular interest in exploring its potential in targeted drug delivery systems and as a scaffold for developing novel bioactive molecules. The mixture of isomers aspect may offer unexpected advantages in these applications, warranting further study.
Environmental considerations for 4-aminoadamantan-1-ol hydrochloride are an emerging area of research. While adamantane derivatives are generally considered stable, their environmental fate and potential ecological impacts require proper assessment. Sustainable chemistry approaches are being developed to optimize the synthesis and application of this and related adamantane-based compounds.
In conclusion, 4-aminoadamantan-1-ol hydrochloride, mixture of isomers (CAS No. 20098-19-5) represents a fascinating chemical entity with diverse potential applications. Its unique structural characteristics, combined with the complexity introduced by the isomeric mixture, make it a valuable tool for researchers in pharmaceuticals, materials science, and beyond. As scientific understanding of this compound continues to grow, so too does its potential to contribute to solutions for current technological and medical challenges.
20098-19-5 (4-aminoadamantan-1-ol hydrochloride, Mixture of isomers) Related Products
- 62075-23-4(trans-4-Aminoadamantan-1-ol Hydrochloride)
- 185378-81-8(3-(1-Aminopropyl)-1-adamantanol hydrochloride)
- 89951-95-1(1,2-Propanediol, 2-(3-amino-4-methylcyclohexyl)-, hydrochloride)
- 90812-24-1(3-Hydroxy Rimantadine)
- 62058-03-1(trans-4-Aminoadamantan-1-ol)
- 62075-26-7((1s,3s)-4-amino-1-adamantanol Hydrochloride (1:1))
- 75375-89-2(4-Aminoadamantan-1-ol)
- 62058-13-3(cis-4-Aminoadamantan-1-ol)
- 1403864-74-3(4-Aminobicyclo[2.2.2]octan-1-ol hydrochloride)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)